This page includes a list of all Optogenerapy deliverables and access to download the public ones:
This page includes a list of all Optogenerapy deliverables and access to download the public ones:
| Deliverable Number | Deliverable Title | Lead beneficiary | Dissemination level |
| D1.1 | Implant architecture parameters | ETHZ | Confidential |
| D1.2 | Prototypes of foil optoelectronics and optical system development | EURECAT | Confidential |
| D1.3 | Integrated implant prototypes including external module and surgical instruments | BOSTON | Confidential |
| D2.1 | Optogenetic cell line engineering | ETHZ | Confidential |
| D2.2 | Model of optogenetic pathway activation for IFN-þ delivery | geneXplain | Confidential |
| D3.1 | Manufacturing and sterilisation | TUL | Confidential |
| D3.2 | In-mould integration process development | EURECAT | Confidential |
| D3.3 | Opto-electro- mechanical performance report | ETHZ | Confidential |
| D3.4 | Validation of selected sterilisation method for Optogenerapy implant | TUL | Confidential |
| D4.1 | In vitro biocompatibility evaluation | TUL | Confidential |
| D4.2 | In vitro performance results and analysis | ETHZ | Confidential |
| D4.3 | In vivo biocompatibility and performance results and analysis | INSERM | Confidential |
| D4.4 | Surgical protocol for device implantation | NEOS | Confidential |
| D5.1 | Path for regulatory approval and safety risk analysis report | BOSTON | Confidential |
| D5.2 | Technical file draft and safety risk analysis report | BOSTON | Confidential |
| D5.3 | Optogenerapy cost- effectiveness analysis in different EU countries | ERASMUS | Confidential |
| D5.4 | Patient survey results, including gender considerations | ERASMUS | Confidential |
| D6.1 | Project Public Webpage and Data Management Plan | EURECAT | Confidential |
| D6.2 | Report on existing standards and standardization landscape | AENOR | Confidential |
| D6.3 | First Plan of Use and Dissemination of Results (PUDR) | BOSTON | Confidential |
| D6.4 | Public communication materials | EURECAT | Public |
| D6.5 | Final PUDR and Exploitation Agreement | BOSTON | Confidential |
| D6.6 | Final communication materials | EURECAT | Public |
| D6.7 | Innovation Management outcomes analysis | EURECAT | Confidential |
| D6.8 | Training activities report | EURECAT | Confidential |
| D6.9 | Interaction with the standardization system and contribution to standardization report | AENOR | Confidential |
| D7.1 | Setting-up Procemm collaborative Platform | EURECAT | Confidential |
| D7.2 | Project Management Plan | EURECAT | Confidential |
| D7.3 | First Risk Management report | ETHZ | Confidential |
| D7.4 | Second Risk Management report | ETHZ | Confidential |
| D8.1 | H – Requirement No. 1 | EURECAT | Confidential |
| D8.2 | HCT – Requirement No. 2 | EURECAT | Confidential |
| D8.3 | POPD – Requirement No. 3 | EURECAT | Confidential |
| D8.4 | A – Requirement No. 4 | EURECAT | Confidential |
| D8.5 | NEC – Requirement No. 5 | EURECAT | Confidential |
| D8.6 | HCT – Requirement No. 6 | EURECAT | Confidential |